-
Mashup Score: 0Aetna partners with gastrointestinal care company Oshi Health - 1 year(s) ago
Aetna said it would begin offering Oshi’s virtual gastrointestinal care in six states, with plans to expand this year.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 3Genomic biomarkers in metastatic colorectal cancer - 1 year(s) ago
Skip to content Genomic biomarkers in metastaticcolorectal cancer In this focus on genomic biomarkers in mCRC, VJOncology delves into… ✓ The current standard practice for biomarker testing ✓ The challenges and barriers to biomarker testing ✓ Potential treatment directions in the future Current biomarker testing guidelines for colorectal cancer John Strickler,…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Patients reported superior outcomes at 1 year compared with gastroenterologist-only standard care
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
Henry Ford Health, 2nd Annual Henry Ford Cancer Gastrointestinal & Neuroendocrine Multidisciplinary Symposium – 5/19/23, 5/19/2023 7:30:00 AM – 5/19/2023 3:00:00 PM, Gastrointestinal & Neuroendocrine Symposium, providing the latest information on Germline Mutations, ctDNA Testing, Localized Pancreatic Cancer, Radiation, Metastatic Colorectal Cancer, Immunotherapies, and other topics in a…
Source: hfhs.cloud-cme.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1
Stacey Cohen, MD, Fred Hutchinson Cancer Center, Seattle, WA, comments on how genomic testing for molecular aberrations can influence treatment…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The latest in targeted therapies for advanced colorectal cancer - 1 year(s) ago
Richard Kim, MD, Moffitt Cancer Center, Tampa, FL, provides an overview of actionable mutations and targeted therapies for patients with…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 0
Chronic granulomatous disease (CGD) is a rare inborn error of immunity, resulting from a defect in nicotinamide adenine dinucleotide phosphate (NADPH) oxidation and decreased production of phagocyte reactive oxygen species. The main clinical manifestations are recurrent infections and chronic inflammatory disorders. Current approaches to management include antimicrobial prophylaxis and control of…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 1Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study - 1 year(s) ago
Not all mutations related to TMB-H can enhance antitumour immune response. More composite biomarkers should be investigated (eg, mTMB signature) to tailor treatment with immune checkpoint inhibitors. Our data also provide novel insights for the combination of immune checkpoint inhibitors and drugs targeting cyclin D1 or FGFs.
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Geriatric assessment and the variance of treatment recommendations in geriatric patients with gastrointestinal cancer—a study in AIO oncologists - 1 year(s) ago
Geriatric assessment (GA) is recommended to detect vulnerabilities for elderly cancer patients. To assess whether results of GA actually influence the treatment recommendations, we conducted a case vignette-based study in medical oncologists.
Source: Esmo OpenCategories: Hem/Oncs, Latest HeadlinesTweet
.@Aetna partners with #gastrointestinal care company @OshiHealth - Aetna said it would begin offering Oshi's virtual gastrointestinal care in six states, with plans to expand this year https://t.co/mnakA2p8Vo